Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v1-EN
Language English English
Date Updated 2021-12-08 2021-10-14
Drug Identification Number 02126559 02126559
Brand name IMDUR IMDUR
Common or Proper name isosorbide-5-mononitrate extended release tablets isosorbide-5-mononitrate extended release tablets
Company Name JUNO PHARMACEUTICALS CORP. JUNO PHARMACEUTICALS CORP.
Ingredients ISOSORBIDE-5-MONONITRATE ISOSORBIDE-5-MONONITRATE
Strength(s) 60MG 60MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100's 100's
ATC code C01DA C01DA
ATC description VASODILATORS USED IN CARDIAC DISEASES VASODILATORS USED IN CARDIAC DISEASES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-10-14 2021-10-14
Actual start date 2021-10-14 2021-10-14
Estimated end date 2022-02-28 2022-01-31
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments